No Palantir in the NHS! Campaign Toolkit

, , ,
Protesters in front of Palantir's London HQ behind a No Palantir in the NHS banner with Palestine flags.
Photo: Talia Woodin
Health Workers for a Free Palestine
Corporate Watch

Introduction

Helpful links and contacts

What is Palantir?

What is the NHS FDP contract? How did Palantir get it?

Data privacy, profiteering and surveillance

Outsourcing, privatisation and quality concerns

How can we disrupt the rollout and get the contract cancelled?

Draft open letter to trustees

Example Freedom of Information request

Introduction

This resource is developed to help community groups, health workers, BDS activists and patients organise against Palantir in the NHS. It contains months of research and investigation, and should help you to get started on organising within your community, trade union, hospital and beyond. We hope this resource allows you to build relationships, connect with different struggles, and create spaces of health justice organising that feel joyful and powerful. 

Organising against the Palantir contract is not only a Palestine solidarity issue. The contract also represents an increase in the state’s ability to surveil health data, which we know will impact marginalised patients the most. It also furthers privatisation and outsourcing of NHS services, and enables corporations to extract and profit from our health data. 

This toolkit is born from the desire to stand in solidarity with Palestinians in their struggle for liberation from occupation, apartheid and settler-colonialism. Over the past year, Health Workers for a Free Palestine (HW4FP) have organised boycotts, direct action, political education, and other forms of disruption. We ground our actions in the political framing of health justice, and our campaign against Palantir has come in response to the call from Palestinian health unions to cut our institutions’ ties to genocide. This campaign has grown far beyond HW4FP and is supported by many other organisations including Just Treatment, Health Workers for Palestine, Medact and Corporate Watch.

This toolkit has a broader purpose than one campaign. The increasing militarisation, privatisation and surveillance of our health services are part of a wider picture of colonialism and capitalism. Med-tech is a key area of collaboration between the UK and Israel – we recognise that Palantir is not the only possible target, but it is a highly strategic one. We aim to weaken a key military supporter of the Israeli state, as well as resist the ongoing outsourcing, asset stripping and privatisation of the NHS and the infiltration of state surveillance technologies into the NHS.

Support is available for research (e.g. what has been happening in my trust with Palantir) and advice on messaging, community organising and strategy. The Palantir campaign holds monthly meetings where local campaigners can send representatives for discussion and shared learning, and has a Signal group for us to share knowledge. 

  • Please let us know if you set up a local group so that we can direct people to you if they approach us and we can add a representative to this group, and reach out if you would like support, advice or research. 
  • You can reach us via Medact, Just Treatment, Health Workers for a Free Palestine, Health Workers for Palestine and Patients not Passports organisers. 

This online tool, developed by Just Treatment, is for NHS patients, staff, and the public to complain about the FDP to their local NHS organisations.

You can leaflet at local community events, Palestine marches, and outside hospitals, you can use our pre-developed leaflet.

You can also find out whether your NHS trust is currently rolling out FDP products! Check the lists of trusts already signed up, or send an FOI request yourself!

You can pass motions at your local union branch using the Just Treatment model union motion.

Helpful articles and powerful reading

What is Palantir?

Graphic showing Peter Thiel in a suit speaking into a microphone
Graphic: Corporate Watch

Palantir is a US tech company, initially funded by the CIA, which specialises in AI-powered military and surveillance technology and data analytics. Palantir describes its military technologies as offering customers (which include the US military, ICE, the UK Ministry of Defence and the Israeli government) “mission-tested capabilities, forged in the field” to deliver “a tactical edge – by land, air, sea and space”. 

Palantir’s previous involvement in state surveillance, racist policing and human rights violations includes:

  • Operation of predictive policing services to US police forces, shown to disproportionately target Black communities
  • Provision of services to the US military for wartime operations in Iraq and Afghanistan
  • Support to the USA to develop artificial intelligence software for war drones, continuing this with the Pentagon’s Project Maven
  • Support to the US government to track and deport migrants at the Mexico border, including in forcibly separating children from parents
  • Support to the US spy-agency NSA and UK spy-agency GCHQ in software for mass surveillance of populations 
  • Links with Cambridge Analytica in its operations to collect data on Facebook users and interfere in the Brexit referendum.

Palantir is very explicit about its political beliefs. It positions itself as a supporter of the “noble, endearing and potentially durable project of the West”. In November 2023, Alex Karp, Palantir’s Chief Executive Officer, stated:

“There is no such thing anymore of being on all sides. Palantir only supplies its products to Western allies. We’ve never supplied our products to enemies. We proudly support the US government.” 

@PalantirTech tweet from July 18 2029: “Silicon Valley is telling the average American ‘I will not support your defense needs’ while selling products to countries that are adversarial to America. That is a loser position."

Its long term aim is to have significant control over most government services, including healthcare. “We are working towards a future where all large institutions in the United States and its allies abroad are running significant segments of their operations, if not their operations as a whole, on Palantir,” Karp wrote in a 2022 letter to shareholders. “Most other companies are targeting small segments of the market. We see and intend to capture the whole.” 

Palantir, Israel and enabling genocide

Palantir is currently openly supporting the Israeli military and government in their genocide on Gaza. It reports being “proud to support Israel in every way [it] can”. It says it is working with Israel to keep them “armed and ahead”.

In January 2024, Palantir signed a deal with the Israeli Occupation Forces (IOF) to increase its “advanced technology provision” to Israel in support of war related missions. Palantir’s CEO Alex Karp says he is “exceedingly proud” of Palantir’s involvement in what he calls “operationally crucial operations in Israel”. Palantir recently launched an AIP (Artificial Intelligence Platform), which claims to be able to analyse enemy targets and propose battle plans. 

“This is not a small issue. From my perspective it’s not just about Israel,” Karp told CNBC In March 2024. “Do you believe in the West? Do you believe that the West has created a superior way of living? Are you willing to admit you believe that?”

Palantir has been closely involved in the Israeli occupation for years. It has operated its own research and development centre in Israel since 2013. It is also closely linked with Carbyne, with shared investors including Peter Thiel and Palantir employees on the board of advisors. Carbyne is an Israeli tech development firm developed by former Mossad and special Unit 8200 IDF members. 

Crucially, Palantir provides predictive policing services to Israel used to surveil Palestinians, especially via social media. In September, Palantir launched its Government Web Services, boasting that “the capabilities that we were able to give the Israeli government…was incredible”. Much like other tactics of oppression, digital technology and surveillance tools developed and used by Israel are ‘field-tested’ on Palestinians and replicated across the world. For example, its predictive policing services are currently used by the US police forces to target poor and Black communities. 

Palantir is part of a network of military, surveillance, investment and technology companies profiteering off genocide, occupation, border violence and policing. For example, Quadrature is a major shareholder in Palantir. As openDemocracy reported, Quadrature also has “significant holdings in the arms manufacturers Northrop Grumman ($31m) and Lockheed Martin ($6m); US private healthcare companies such as UnitedHealth ($31m) and HCA Healthcare ($16m); some of the largest asset management companies like Blackstone ($22m) and KKR ($7m), who potentially stand to benefit significantly from Labour’s plans to utilise private investment for infrastructure; and tech firms, including Palantir ($71m) and Oracle ($8m)”. Quadrature recently donated £4 million to Keir Starmer’s Labour Party. 

What is the NHS FDP contract? How did Palantir get it?

Graphic showing Palantir key figures on an abstract network coming out of a syringe held by a blue-glovedhand
Image: Corporate Watch

In November 2023, Palantir was awarded a £330 million contract to create a new data management system called the Federated Data Platform (FDP) that aims to provide ‘joined up’ NHS services. This would possibly be the largest population health dataset in the world.

Senior Palantir staff infamously described the company’s NHS strategy as “buying our way in” and “hoovering up” small businesses working with the NHS to “take a lot of ground and take down a lot of political resistance”. 

Covid-19 contracts

In March 2020, as the global pandemic exploded, Dominic Cummings and Simon Stevens (then NHS CEO) called a meeting on how to tackle Covid-19 with several big tech companies, including Palantir. The next day it signed a deal for its software to be used to create a Covid-19 database for just £1 for the first three months. This contract was given without competitive tender. Matt Hancock used special ministerial powers to bypass patient confidentiality rules and allow the company to process patient data

In the following months, Palantir was handed several more NHS data and digital contracts, all while normal procurement procedures were paused. Its initial ‘friendly’ offer of a £1 contract paid off and by Nov 2023, Palantir had earned £60.5m and went on to win the FDP contract itself.

Revolving doors, Israeli ambassadors, M16 and cocktail parties

Palantir’s path to power has been facilitated by cultivating close relationships with senior NHS staff and government officials, as well as funding think tanks such as Policy Exchange and Institute for Government. 

The tech company has worked with consultants and lobbyists to further its reach into, and influence over, the NHS. These include, Peter Mandleson’s Global Counsel, and Isaac Levido’s Fleetwood Strategy. It also employed former senior figures from the health service, hosted cocktail parties for key NHS and government officials, embedded staff in important positions, and made donations to MPs

One of the main figures involved in helping Palantir get contracts during the pandemic was the former British Ambassador to Israel, Matthew Gould. As CEO of NHSX, he recommended to Ministers that they “used emergency powers to award the contract to Palantir”. Gould also had meetings with Palantir in 2019, months before it got its first NHS contract. He now works for a private tech company working in the NHS. 

While Gould was CEO of NHSX he oversaw the creation of the UK-Israel Tech Hub in 2011. This Hub – based in the British Embassy in Israel – is a unique government partnership that fast tracks business for Israeli tech companies in the UK in areas such as cyber and health. It has deep links to the Israeli military and intelligence services. The chair of the Hub is Haim Shani, who until recently was a director of Cellebrite – the Israeli intelligence company involved in international hacking scandals. 

Palantir was referred to as the recipient of NHS funding even before official decisions had been made, an email exchange from 2020 revealed, leading to accusations of an unfair procurement process for the FDP. Senior NHS executives involved in this discussion included Ming Tang, one of the key people working closely with Palantir in the last few years. Tang, who is currently the Chief Data and Analytics Officer for NHS England, was also recently a ‘guest of honour’ at a Palantir lobbyist dinner. 

Some other key figures: 

  • Dr Indra Joshi was director of AI for NHSX until 2022 when she took a role as director of health, research and AI with Palantir. 
  • Harjeet Dhaliwal has been a deployment strategist at Palantir since 2022. She was Deputy Director of Data Services for NHS England from 2019 to 2022 and before that spent the previous 12 years either working with health commissioning in England, or working directly with data in NHS roles.
  • Paul Howells was the leader of the National Data Programme between 2018 – 2021 for NHS Wales, before joining Palantir to work on health and care.
  • Justin Whatling came to work with Palantir from Cerner in 2021. He is currently an advisor to CW+, the official charity of Chelsea and Westminster Trust, the health trust being lauded as ‘best in show’ when it comes to Palantir’s FDP pilot products. 
  • Matthew Swindells, once named the 4th most influential person in the NHS, was one of the first NHS ‘stars’ to join Global Counsel after leaving his NHS role as Deputy Chief Executive and Director of Operations and Information in 2019. Just two months later, he was working with Palantir in his new position. 
  • Palantir also has contracts with other UK government bodies, including the Cabinet Office. Palantir won a £27m border control contract, without competitive tender, with the Cabinet Office after being introduced to it by the former head of M16. 

The current health secretary, Wes Streeting, is a vocal advocate of the FDP, with strong links to the Israeli med-tech industry and the Israeli lobby. In a recent speech bemoaning the slow adoption of the FDP he said “when I’ve heard people say ‘I’m not sure about Palantir’, or ‘I’m not sure that the NHS has a really good track record on this sort of project’, I’m sorry, but that doesn’t wash with me”.

Data privacy, profiteering and surveillance

Who will have access to the data?

It is unclear who will have access to the data shared through the FDP as many of the potential future uses of the FDP have yet to be defined, but the new government has stated policy goals to “make [NHS] datasets more open to business, researchers, and citizens”. 

NHS leaders have previously stated that the data handled by Palantir will be “pseudo anonymised” and Palantir will not have access to “identifiable” patient information (without the permission of the NHS) or be able to “sell on” the data. Given its record of abuses, there is widespread concern that Palantir would not abide by any such restrictions. Furthermore, pseudonymisation is designed to be reversible, and is still regarded as personal data by the Information Commissioner.

  • Previous contracts with Palantir and the NHS have involved data sharing including dates of birth, postcodes and detailed medical histories. Despite claiming that Palantir would not have access to “identifiable medical records”, NHS documents obtained by openDemocracy admitted that the company will “collect and process confidential patient information”. 
  • This dishonest or inaccurate communication about its historic access to patient data significantly undermines trust in the NHS’s current assurances that Palantir won’t have access to this data in the FDP. There are multiple inconsistencies and gaps in information communicated to the public about the way data will be held, for what purpose, and with what safeguards over its use.
  • NHS England has hired a second company to support the processing of the data and confidentiality. Documents shared with the FDP board in March show that NHS England had received legal advice showing a vital aspect of the program – its privacy-enhancing technology (PET), to be provided by IQVIA – lacked a legal footing to proceed.

Patient rights and involvement

Many leading medical and data ethics experts have voiced alarm at the supposed safeguards put in place to protect patient data within the FDP, including the BMA, who wrote to the government last year arguing: “The public and the profession have not been adequately consulted and reassured, and the scope and scale of the programme do not appear to have been sufficiently established.” The lack of trust over how patient data would be handled gave the BMA concerns that it would fatally undermine the project.

NHS England has reversed its initial commitments and stated that patients will not be able to opt-out of having their data used in the FDP. There has been a serious failure to consult patients on the FDP. These weak reassurances, along with the lack of clarity around the applicability or otherwise of the national data opt-outs to the FDP mean that there are persistent fears over the data privacy protocols to be implemented by the NHS, Palantir, and others involved in the project. 

This lack of trust in the FDP – particularly one run by a private company like Palatir is a serious concern, as it risks undermining the potential benefits to be realised from effective, trusted use of health data for planning and care. This threat was highlighted by Dr Nicola Byrne, the National Data Guardian, who argued that the lessons must be learned from the failures of past data centralisation efforts such as care.data and GDPR if mass opt outs are not to undermine the FDP. This risk could play out, with 48% of adults in England who have not yet opted out stating in response to a YouGov poll commissioned by Foxglove and the Doctors Association, that they are likely to do so should the Federated Data Platform be introduced and run by a private company.

How does this increase the capacity for surveillance?

This deal also comes at a time when the UK Home Office has attempted multiple times to get access to migrant health data and track their location. Existing mechanisms such as Prevent, migrant charging and data sharing with the Home Office have made doctors into border guards and turned the NHS into a place of policing and surveillance for some patients. 

There is a dangerous track record of data being shared across government departments to target vulnerable communities including migrants and refugees, including NHS patient data. Campaigners are rightly alarmed that the FDP will make this even easier, especially as there is still so much uncertainty about the full scope of the FDP and uses of the data collected within it. 

The involvement of Palantir only adds to these concerns. It has supported the US spy-agency NSA and UK spy-agency GCHQ in software for mass surveillance of populations, and was linked with Cambridge Analytica in its operations to collect data on Facebook users and interfere in the Brexit referendum. 

Palantir is already embedded extensively within the UK government, including processing border and customs data and military decision making, making the deal even more concerning. It has contracts with the Ministry of Defence, the Home Office, DHSC, the Cabinet Office, the police and other arms of the state. In this context, Palantir’s insistence that “only the UK government” will control what happens to the FDP’s unprecedented collection of data, is not reassuring.

Screenshot of Just Treatment's Online Tool: "NHS Trusts: Resist the rollout of Palantir’s Federated Data Platform! – Despite widespread concerns raised by patients, health workers, and human & data rights campaigners, last year the Conservative government awarded a £330m contract to US spy tech company Palantir to run a giant database of our NHS health data - called the Federated Data Platform (FDP).

Palantir - a company with a track record in military technology and surveillance, which actively celebrates its deep involvement in ongoing war crimes in Gaza - is a totally inappropriate partner for our NHS."
Take action with Just Treatment’s online tool!

What will Palantir gain from the data?

The NHS dataset is possibly the largest complete health dataset in the world. The opportunity to test and develop its software in the NHS is a highly valuable resource in itself, which Palantir could profit significantly from. Amnesty International highlighted: “Even if [Palantir] cannot walk away with direct patient records, they can walk away with the lucrative AI models built from those records.”

Research by Privacy International and No Tech for Tyrants into rare, unredacted contracts, shows that Palantir seeks to include “improvement clauses” in its agreements with governments, enabling it to improve its algorithms or systems based on its customers’ use of its products. With NHS data therefore likely being used to strengthen Palantir’s tools, this could ultimately result in the NHS contributing to the advancement of technology used to commit human rights abuses and war crimes, including in Gaza by the Israeli state. 

Outsourcing, privatisation and quality concerns

Locking the NHS into a single monopoly supplier holds severe risks, especially when Palantir itself has stated its intention to monopolise government contracts with its technology. Palantir’s software cannot be transferred to another company or back onto NHS systems easily. This means that the whole of NHSE’s integrated data system will be stuck on Palantir’s systems or will need to be rebuilt from scratch. This exact issue played out when the NYPD tried to end its use of Palantir’s technology. This is neither democratic or competitive, and will result in one private provider dominating the data management systems of the NHS. 

A private-sector-first model means the FDP is entrenching further outsourcing and privatisation within the NHS, and the FDP rollout with a single service provider in Palantir risks locking the NHS into a monopoly controlled data management future that only serves the interests of the company. In January 2023, Palantir CEO Peter Thiel described Britons’ affection for the NHS as “Stockholm syndrome” and urged the government to “rip the whole thing from the ground and start over”.

This is happening at the cost of building up NHS capacity and expertise to deliver these kinds of tools in-house. Many doctors and other NHS experts have serious misgivings about the FDP, with the enforced rollout likely preventing them from using other, better tools. Even the head of the FDP admitted that it “will not be spectacular”.

The CEO of Leeds Teaching Hospitals Trust warned NHSE that many of the FDP’s key features are worse than some of the services it already uses: “From the descriptions we have of these FDP products we believe we would lose functionality rather than gain it by adopting them.”

How can we disrupt the rollout and get the contract cancelled?

We believe the weakest link in the rollout is at the local trust level, where it will be clear that communities, patients and workers will not accept this contract.

Protesters in front of Palantir's London HQ behind a No Palantir in the NHS banner with Palestine flags.
Photo: Talia Woodin

There are ongoing legal challenges to the contract by Foxglove and Good Law Project. Many open letters to NHS England, including from high profile doctors and law firms, have been unsuccessful. We are and will continue to work with NHS England staff members who are opposed to the contract, but must build power in our workplaces and communities to get this cancelled. 

The rollout of the FDP is heavily dependent on each trust adopting it, and developing local ‘applications’ using it. The FDP will sit above all of this, integrating data that it obtains from the applications. These two diagrams are taken from NHS England:

Screenshot from NHS England Website:
"Part 1 – diagram of the contractual documentation:
This diagram shows the contractual structure for the federated data platform (FDP) and the privacy enhancing technology NHS-PET. It also shows the relationship of responsibilities between the two processors, Palantir (FDP) and IQVIA (NHS-PET), and the three controllers, NHS England, integrated care boards and acute trusts."

Initially, the rollout began with pilot trusts developing the FDP. Each trust and hospital will use it slightly differently, and some have been working directly with Palantir to develop functions, such as Chelsea and Westminster’s ‘Cancer 360’ application. The ‘products’, developed and piloted at trusts, if successful, will be rolled out or offered to other trusts across England. In trusts where the FDP is being piloted, the Palantir app and Palantir login have started appearing on trust computers. 

Here are some of the products we know about so far, both in development and already available (if you are reading this and you know of others please get in touch so we can update this list):

Live

Incubation period

  • AI Discharge Summaries
  • Assisted Theatre Scheduling
  • Equipment Tracking
  • PLV
  • Pre-Operative Assessment
  • Radiology Bookings Productivity
  • Shared PLT
  • System Control Centre
  • Timely Care Hub

Pilot

  • Cancer 360

Concept stage

  • Cancer Waiting Times
  • LLM Clinical Letters
  • Person Level Costings
  • System Analytics Workbench
  • Virtual Wards

Not Started

  • DNS Prediction
  • Patient Initiated Follow Up 

Other

  • Mutual Aid

Which trusts are rolling out FDP products?

By November 2023, we had info on some initial trusts progress, plus plans for the national rollout. By January 2024, we had more info on specific trusts’ progress and what products they had, and we knew there were 42 trusts piloting the FDP in some way.

Trusts that we know are piloting Palantir software:

By March 2024, we knew there were 29 new trusts being prepped. We sent a Freedom Of Information request to NHSE for the names of the (now known number of) 44 trusts, and the 29 more intended to have gone live in summer 2024. We were refused on the grounds that this information was supposed to be published in summer 2024 on NHSEs own website; this has not yet been published. 

Originally, adoption of the FDP was going to be voluntary. In August 2024, NHS England announced it would be mandatory for trusts to implement the FDP, giving them only a few days to confirm their plans and two years to implement them. NHSE mandating the use of the FDP is highly unusual and problematic, with unclear legal basis. Since then, over half of acute trusts have signed up to implement the FDP. 

Our most recent FOI to NHSE regarding the (still unpublished) list of trusts actively rolling out the FDP, and Palantir’s products, was partially answered and we were given a list of trusts known to be in early engagement in March 2024. We were also successful in getting a list of integrated care boards (ICB) that have formally agreed to join the NHS FDP Programme via completion of a Memorandum of Understanding in October 2024. Again, this is a snapshot in time and can change regularly.

What are the key messages of the campaign?

  1. Palantir are an unacceptable partner The NHS cannot partner with a company complicit in genocide and multiple human rights abuses. Palantir’s AI will benefit significantly from this contract, which could potentially lead to NHS health data being used to improve and strengthen technology that is used for human rights abuses and war crimes. 
  1. The FDP, especially with Palantir leading, will damage patient trust in health data and furthers capacity for state surveillance – The FDP hugely expands capacity for state and corporate surveillance of health data, and there is no patient opt out. This is exacerbated by the company running it being Palantir, known for human rights abuses and state surveillance, which stands to benefit significantly from this contract. This will lead to a lack of patient trust in the FDP and other health data systems, with known negative impacts on care. 
  1. The contract with Palantir futhers the outsourcing, privatisation and asset stripping of the NHS – This contract enables a private corporation to become embedded and essential to the functioning of health data systems. The money spent on the contract would be better spent developing trusted and effective internal publicly-run data systems. 

Key demands for NHS England

  • Cancel the contract with Palantir
  • End the outsourcing, privatisation and asset stripping of the NHS
  • End all contracts with companies complicit in the Israeli occupation

(There are multiple other BDS target possibilities within the health system. We have focussed on Palantir as a strategic target but others include (but are definitely not limited to) big tech companies, Oracle and Infosys.)

Additional demands for trusts and hospitals

  • Do not implement the FDP locally and/or pause any existing rollout plans
  • Raise these concerns nationally and oppose the enforced rollout on all trusts
  • Publicly and clearly communicate the trust’s position on the FDP
  • Explain whether – and how – patients can opt out of including our data in the FDP

How can I get started?

Organise a local group

  • Find a group of people in your local area who care about Palestine, data privacy, migrant rights in the NHS, surveillance, privatisation or all of them!
  • Take your time to get to know each other and set shared aims and intentions. This is an important issue, but we also have time (years) to build resistance to it, so you don’t need to rush.
  • Once you have your core group, you can start regular meetings and brainstorm how you would like to approach this in your area.

Please let us know if you set up a local group so that we can direct people to you if they approach us and we can add a representative to the Palantir campaigning Signal group. 

Gather information

Find out whether your local trust or ICB is beginning to implement the FDP by checking whether it is on one of the following lists:

You can also send an FOI to your trust finding out its FDP plans (see draft FOI below).

Build relationships

  • A lot of health workers feel nervous or scared to organise in their workplace. Doing things together helps to build up trust and confidence, and reassures you that you can do political organising together.
  • You could start with discussions about issues in your workplace that people feel strongly about, such as migrant charging for healthcare, data privacy and Palestine.
  • You could gather people together to read this toolkit and discuss it together.
  • You could start by running political education events or workshops on Palantir and the NHS contract. Get in touch with Health Workers for a Free Palestine if you would like help with this – we have workshop templates!
  • You can leaflet at local community events, Palestine marches, and outside hospitals – use our pre-developed leaflet!
  • You can pass motions at your local union branch using the Just Treatment model union motion. 

Campaign

  • You could use our draft open letter, adapt it to your local trust/hospital, and gather signatures from health workers to the board of trustees.
  • You can work with community leaders, local Palestine solidarity groups or other groups to encourage people to send in patient and public complaints using the Just Treatment online tool, or writing their own letters and leafleting at hospitals.
  • You can approach your local union representatives (such as the Local Negotiating Committee of the BMA) to ask them to support the campaign, by signing the letter and raising the issue at their regional and national union meetings. You can also use this example union branch motion.
  • You can approach your local union representatives to discuss the possibility of staff refusing to work on the FDP (i.e. less-than-strike action targeted at the FDP). We are also exploring this at the national level.
  • You can lobby your Royal College or other professional body as a group of specialist doctors asking it to object to the contract.
  • You can map and join local health and community engagement committees and meetings, such as integrated care board (ICB) meetings.
  • You can lobby your local council and local MPs to object to the FDP roll out in your local area.

Draft open letter to trustees

This letter is written as if it was from NHS staff, but it can be adapted to any group! This draft letter is long, so feel free to edit it and adjust to your local context. 

Who to write to:

  • You can map the relevant people with power in your hospital or trust. This may include: trust CEO and trustees, trust data officer, clinical director, trust COOs, directors of transformation and improvement, exec/non-exec teams, and trust ethics/procurement teams.

We are writing to you as members of staff at [insert hospital/trust/location] to express our deep concern at the rollout of the Federated Data Platform (FDP), and the supplier of this technology, Palantir. As we will outline below, we believe this contract represents a serious threat to NHS values and trust values, and undermines our commitment as health workers to promote public health, medical ethics, patient trust, good data governance and fair procurement.

[Insert paragraph on current situation at trust (adjust depending on how much information available, please contact hw4fp research team for support if needed):

  • We are aware that X hospital has participated in the pilot scheme 
  • We are aware that X hospital has begun using X applications
  • We are aware that the Palantir logo has started appearing on trust computers
  • We are aware that NHS England has mandated all trusts to confirm their plans to roll out the FDP over the next two years]

[Given X trust’s commitment to (insert various trust statements, in particular on anti-racism, inclusion, child health, etc)], we hope that the trust will object to the roll out of the FDP, and support ethical, safe and fair data management systems. 

  1. Palantir, the provider of the FDP, is likely complicit in human rights abuses, war crimes and genocide 

Palantir is a US tech company which specialises in AI-powered military and surveillance technology and data analytics. Palantir describes its military technologies as offering customers “mission-tested capabilities, forged in the field” to deliver “a tactical edge – by land, air, sea and space”. 

Palantir has a long history of using its technology to facilitate human rights abuses across the world. It supported the US government to track and deport migrants at the Mexico border, including in forcibly separating children from parents. It provides predictive policing services to the US police force, shown to disproportionately target Black communities. It provided services to the US military for wartime operations in Iraq and Afghanistan, in particular drone strikes, which are known to have targeted civilians. 

Most recently, Palantir is currently supplying the Israeli military with “advanced technology provision” in support of war related missions. Palantir’s CEO Alex Karp says he is “exceedingly proud” of Palantir’s involvement in what he calls “operationally crucial operations in Israel” keeping Israel “armed and ahead”. 

The most recent International Court of Justice (ICJ) ruling regarding Palestine came in July 2024, with an Advisory Opinion that declared Israel’s occupation of Palestine unlawful under international law, specifically mentioning forcible transfer, racial discrimination and apartheid, and it called for Israel to withdraw immediately. The ICJ also laid out directions for the responsibility of states and international organisations and stated that failing to act was furthering ‘genocidal violence’. In relation to the ICJs case on genocide it said that if states didnt cease their aid and assistance to Israel’s acts, they would be complicit, and this includes transfer and trade that contributes to Israel’s military. By supplying advanced AI technology to the Israeli military, it is likely that Palantir is complicit in war crimes and genocidal violence. 

With all of the above evidence, we hope that the trust will agree that Palantir is an unacceptable partner for the trust and NHS England, and rolling out its technology in the FDP will undermine the trust’s commitments to [insert] and damage patient relationships. It will also compromise our commitments as health workers to protecting, promoting and maintaining the health, safety and wellbeing of the public, and promoting and maintaining public confidence in the medical professions. 

  1. There are serious concerns about the data privacy, data management, and data ethics of the FDP

Many leading medical and data ethics experts have voiced alarm at the supposed safeguards put in place to protect patient data within the FDP, including the BMA, who wrote to the government last year arguing: “The public and the profession have not been adequately consulted and reassured, and the scope and scale of the programme do not appear to have been sufficiently established.” The lack of trust over how patient data would be handled gave the BMA concerns that it would fatally undermine the project.

The NHS has sought to reassure patients that their data will be safe because it is “pseudonymised” or “anonymised” but the level of detail in a health record means such data can never be truly confidential, with a small number of data points being enough to reveal the identity of the patient. Furthermore, pseudonymisation is designed to be reversible, and is still regarded as personal data by the Information Commissioner.

These weak reassurances, along with the lack of clarity around the applicability or otherwise of the national data opt-outs to the FDP mean that there are persistent fears over the data privacy protocols to be implemented by the NHS, Palantir and others involved in the project.

There is a dangerous track record of data being shared across government departments to target vulnerable communities including migrants and refugees, including NHS patient data. Campaigners are rightly alarmed that the FDP will make this even easier, especially as Palantir has multiple relationships with departments across government, and there is still so much uncertainty about the full scope of the FDP and uses of the data collected within it.

These legitimate concerns over the way NHS patients’ data will be used within the FDP are exacerbated by the multiple inconsistencies and gaps in information communicated to the public about the way data will be held, for what purpose, and with what safeguards over its use.

This lack of trust in the FDP – particularly one run by a private company like Palatir – is a serious concern, as it risks undermining the potential benefits to be realised from effective, trusted use of health data for planning and care. This threat was highlighted by Dr Nicola Byrne, the National Data Guardian, who argued that the lessons must be learned from the failures of past data centralisation efforts such as care.data and GDPR if mass opt outs are not to undermine the FDP. This risk could play out, with 48% of adults in England who have not yet opted out stating in response to a YouGov poll, commissioned by Foxglove and the Doctors Association, that they are likely to do so should the Federated Data Platform be introduced and run by a private company.

Such mass opt outs not only undermine the quality of the data for researchers, but are also likely to entrench health inequalities as more people in some ethnic minority communities are likely to take this step, reducing their visibility when health planning is undertaken. Failing to do this with informed consent and support from patients is going to worsen health outcomes for many within the UK – even if the FDP reality matches the hype.

The involvement of Palantir only adds to these concerns. It has supported the US spy-agency NSA and UK spy-agency GCHQ in software for mass surveillance of populations, and was linked with Cambridge Analytica in its operations to collect data on Facebook users and interfere in the Brexit referendum. 

Previous contracts with Palantir and the NHS have involved sharing including dates of birth, postcodes and detailed medical histories. Despite claiming that Palantir would not have access to “identifiable medical records”, NHS documents obtained by openDemocracy admitted that the company will “collect and process confidential patient information”. This dishonest or inaccurate communication about its historic access to patient data significantly undermines trust in the NHS’s current assurances that Palantir won’t have access to this data in the FDP.

Even if there was total clarity about the safeguards in place, and a public commitment to the highest standards of data privacy and ethics, it would – according to Conservative MP, David Davis – make little difference: “Bluntly, it is the wrong company to put in charge of our precious data resource; even if it behaved perfectly, nobody would trust it.

The opportunity to test and develop its software in the NHS is a highly valuable resource in itself, which Palantir could profit significantly from. Amnesty International highlighted: “Even if (Palantir) cannot walk away with direct patient records, they can walk away with the lucrative AI models built from those records.” Research by Privacy International and No Tech for Tyrants into rare, unredacted contracts, shows that Palantir seeks to include “improvement clauses” in its agreements with governments, enabling it to improve its algorithms or systems based on its customers’ use of its products. With NHS data therefore likely being used to strengthen Palantir’s tools, this could ultimately result in the NHS contributing to the advancement of technology used to commit human rights abuses and war crimes, including in Gaza by the Israeli state. 

With all of the above evidence, we hope the trust realises the threat to data privacy this contract presents, and the potential follow-on damage to patient trust in all health data systems. Previous software rollouts have been paused and reversed due to patient and health worker concerns over data privacy, and we believe the FDP will meet the same issues. We believe the government has failed to uphold its legal obligations to secure informed consent for the use of patient data, demonstrate the legal footing for the FDP, and adequately address the concerns of doctors and patients alike. 

  1. We have serious concerns about the privatisation and outsourcing of health data management systems to corporations

We have serious concerns that such an important NHS function as data management systems is being outsourced to a private company. Locking the NHS into a single monopoly supplier holds severe risks, especially when Palantir themselves have stated its intention to monopolise government contracts with its technology. Palantir’s software cannot be transferred to another company or back onto NHS systems easily. This means that the whole of NHSE’s integrated data system will be stuck on Palantir’s systems or will need to be rebuilt from scratch. This exact issue played out when the NYPD tried to end its use of Palantir’s technology. This is neither democratic or competitive, and will result in one private provider dominating the data management systems of the NHS. In January, 2023 Palantir CEO Peter Thiel described Britons’ affection for the NHS as “Stockholm syndrome” and urged the government to “rip the whole thing from the ground and start over”. 

The procurement process for Palantir raises serious concerns for mismanagement, ministerial intervention and unfair procurement processes. Palantir initially entered the NHS by providing its services for just £1, in a contract that was given without competitive tender. The Health Minister at the time, Matt Hancock, used special ministerial powers to bypass patient confidentiality rules and allow the company to process patient data. In the following months, Palantir was handed several more NHS data and digital contracts, all while normal procurement procedures were paused. 

This gave Palantir significant advantages in the FDP procurement process. Palantir was referred to as the recipient even before official decisions had been made, an email exchange from 2020 revealed, leading to accusations of an unfair procurement process for the FDP. In addition, NHS England’s decision to mandate the use of the FDP is highly unusual, and has an unclear legal basis. 

We hope the trusts agree that this raises serious concerns of an unfair procurement process, putting vital NHS resources at risk of failing to secure value for money. Instead of outsourcing valuable financial and personnel resources, and locking in dependency on private companies, we believe the NHS, and the trust, should focus on developing strong in-house data management capabilities.

Our requests to the trust are as follows:

  1. Do not implement the FDP locally and/or pause any existing rollout plans
  2. Raise these concerns nationally and oppose the enforced rollout on all trusts
  3. Publicly and clearly communicate the trust’s position on the FDP
  4. Explain whether – and how – patients can opt out of including their data in the FDP

Example Freedom of Information request

Please send your FOI using the website WhatDoTheyKnow, which means the responses are public and easily shareable. 

To whom it may concern,

This is a Freedom of Information request for information relating to the letter this summer from Dame Emily Lawson and Vin Diwaker, to all trust executives and COOs, asking them to confirm “that [they] plan to adopt the NHS FDP in the next two years”.

Source: https://www.digitalhealth.net/2024/08/nhs-england-says-trusts-must-start-using-fdp-within-two-years/

I would like to see all emails, documents, attachments, and any other forms of response relating to this request between [INSERT TRUST NAME HERE] and the two senior NHS officials.

It is public information that you have been asked to inform the NHS when you “envisage adopting already available nationally commissioned local Products”.

I would like to know when specifically you plan to start adopting the FDP and who you are naming as lead (as is requested in the letter)?

I would also like to know what your plans are for how you will maximise the benefits of the Federated Data Platform to deliver better joined-up care for their patients within the next two years (again, asked of you in the above mentioned letter)?

Yours,

[INSERT NAME]